These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3211364)

  • 21. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory effects of chronic in utero methadone or morphine exposure in the neonatal guinea pig.
    Nettleton RT; Wallisch M; Olsen GD
    Neurotoxicol Teratol; 2008; 30(5):448-54. PubMed ID: 18442893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.
    Chevillard L; Mégarbane B; Risède P; Baud FJ
    Toxicol Lett; 2009 Dec; 191(2-3):327-40. PubMed ID: 19819313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
    Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
    Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of perinatal exposure to methadone on brain opioid and alpha 2-adrenergic receptors.
    Wang C; Pasulka P; Perry B; Pizzi WJ; Schnoll SH
    Neurobehav Toxicol Teratol; 1986; 8(4):399-402. PubMed ID: 3020461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.
    Sanchez ES; Bigbee JW; Fobbs W; Robinson SE; Sato-Bigbee C
    Glia; 2008 Jul; 56(9):1017-27. PubMed ID: 18381654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice.
    Barwatt JW; Hofford RS; Emery MA; Bates ML; Wellman PJ; Eitan S
    Drug Alcohol Depend; 2013 Oct; 132(3):420-6. PubMed ID: 23932842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
    Mello NK; Bree MP; Mendelson JH
    J Pharmacol Exp Ther; 1983 May; 225(2):378-86. PubMed ID: 6188822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Buprenorphine and methadone to opiate addicts--a randomized trial].
    Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone and buprenorphine toxicity in children.
    Boyer EW; McCance-Katz EF; Marcus S
    Am J Addict; 2010; 19(1):89-95. PubMed ID: 20132125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of perinatal buprenorphine exposure on development in the rat.
    Robinson SE; Wallace MJ
    J Pharmacol Exp Ther; 2001 Aug; 298(2):797-804. PubMed ID: 11454944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
    Chiang YC; Hung TW; Ho IK
    Addict Biol; 2014 Jul; 19(4):676-86. PubMed ID: 23551991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.